Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Sell
25
SRXH Quote, Financials, Valuation and Earnings
Last price:
$0.16
Seasonality move
:
445.71%
Day range:
$0.15 - $0.18
52-week range:
$0.15 - $2.44
Dividend yield:
0%
P/E ratio:
0.14x
P/S ratio:
0.03x
P/B ratio:
0.47x
Volume:
29.7M
Avg. volume:
34.1M
1-year change:
-93.13%
Market cap:
$4.3M
Revenue:
$6.5M
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, SRx Health Solutions, Inc. has -- downside to fair value with a price target of -- per share.
SRXH vs. S&P 500
-
Over the past 5 trading days, SRx Health Solutions, Inc. has underperformed the S&P 500 by -18.23% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
SRx Health Solutions, Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SRx Health Solutions, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter SRx Health Solutions, Inc. reported revenues of $7.2M.
Earnings Growth
-
SRx Health Solutions, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter SRx Health Solutions, Inc. reported earnings per share of -$0.07.
Enterprise value:
40.5M
EV / Invested capital:
--
Price / LTM sales:
0.03x
EV / EBIT:
--
EV / Revenue:
1.09x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-9.20x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
-15.2%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Income Statement | ||||||
| Revenue | $40.9M | $35.3M | $37.1M | $8.5M | $11.4M | |
| Gross Profit | $11M | $9.9M | $11.1M | $3.2M | $1.6M | |
| Operating Income | -$17.8M | -$10M | -$18.6M | -$724K | -$14.7M | |
| EBITDA | -$16.1M | -$9.1M | -$16.7M | -$704K | -$12.9M | |
| Diluted EPS | -$55.53 | -$23.09 | -$1.21 | $2.98 | -$0.74 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $17M | $40M | $19.8M | $12.2M | $24.5M | |
| Total Assets | $49.2M | $70M | $30.4M | $13.1M | $34M | |
| Current Liabilities | $24.9M | $7.4M | $11.5M | $9.1M | $74.1M | |
| Total Liabilities | $34.9M | $18.6M | $14.2M | $9.1M | $79.9M | |
| Total Equity | $14.3M | $51.4M | $16.2M | $3.9M | -$45.9M | |
| Total Debt | $10.7M | $12.4M | $4.9M | $1.6M | $30.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$14.4M | $564K | -- | -$1M | $384K | |
| Cash From Investing | -$58K | -$11K | -- | -$3K | -$1.1M | |
| Cash From Financing | -$1.1M | -$4.6M | -- | $430K | -$1.2M | |
| Free Cash Flow | -$14.4M | $553K | -- | -$1M | $377K | |
SRXH
Sector
Market Cap
$4.3M
--
Price % of 52-Week High
6.34%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-93.13%
--
Beta (5-Year)
0.882
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.18
200-day SMA
Sell
Level
$0.56
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.21
Relative Strength Index (RSI14)
Sell
Level
34.05
ADX Line
Neutral
Level
0
Williams %R
Buy
Level
-96.2015
50-day SMA
Sell
Level
$0.28
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-6.324)
Sell
CA Score
(Annual)
Level (-5.1265)
Sell
Beneish M-Score
(Annual)
Level (1.0671)
Buy
Momentum Score
Level (1)
Sell
Ohlson Score
Level (7.7256)
Sell
Piotroski F Score
(Annual)
Level (3)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SRx Health Solutions, Inc. operates as a global health and wellness company. Its services include clinical and pharmaceutical solutions, compounding services, pharmacy services, nursing healthcare, and vaccination services. The company was founded on January 3, 2001 and is headquartered in Tampa, FL.
Stock Forecast FAQ
In the current month, SRXH has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SRXH average analyst price target in the past 3 months is --.
-
Where Will SRx Health Solutions, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that SRx Health Solutions, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About SRx Health Solutions, Inc.?
Analysts are divided on their view about SRx Health Solutions, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SRx Health Solutions, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is SRx Health Solutions, Inc.'s Price Target?
The price target for SRx Health Solutions, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SRXH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SRx Health Solutions, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SRXH?
You can purchase shares of SRx Health Solutions, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SRx Health Solutions, Inc. shares.
-
What Is The SRx Health Solutions, Inc. Share Price Today?
SRx Health Solutions, Inc. was last trading at $0.16 per share. This represents the most recent stock quote for SRx Health Solutions, Inc.. Yesterday, SRx Health Solutions, Inc. closed at $0.15 per share.
-
How To Buy SRx Health Solutions, Inc. Stock Online?
In order to purchase SRx Health Solutions, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SRXH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SRXH
Sector
P/E ratio
0.14x
--
PEG ratio
--
--
P/B ratio
0.47x
--
Price / LTM sales
0.03x
--
Growth Metrics
SRXH
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
-31.27%
--
Earnings forecast
--
--
Profitability
SRXH
Sector
Profitability FY 2025
$1.5M
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Jan
23
Next Earnings Date
Jan
23
Estimated Next Earnings Date
Apr
24
Balance Sheet
SRXH
Sector
Total cash
$1.1M
--
Short term investments
--
--
Total assets
$8.4M
--
Long term debt
$1.2M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Goldman Sachs Going to Go Up?
Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…
How High Will MSTR Stock Go?
After several months of pressure, shares of Bitcoin treasury Strategy…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
69
INTC alert for Jan 23
Intel Corp. [INTC] is down 17.01% over the past day.
Buy
70
BNR alert for Jan 23
Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.
Buy
80
MTRN alert for Jan 23
Materion Corp. [MTRN] is down 9.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
